<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367691/" ref="ordinalpos=2765&amp;ncbi_uid=7319499&amp;link_uid=PMC4367691" image-link="/pmc/articles/PMC4367691/figure/f1/" class="imagepopup">Figure 1.  From: ROR1 as a novel therapeutic target for EGFR-mutant non-small-cell lung cancer patients with the EGFR T790M mutation. </a></div><br /><div class="p4l_captionBody">ROR1 signaling pathway. ROR1 is required to sustain balance between pro-survival and pro-apoptotic signaling through sustainment of EGFR-ERBB3 and c-Src activation. ROR1, orphan receptor 1.</div></div>